Seres Therapeutics names Richard Kender as interim CEO
Go back to Seres Therapeutics names Richard Kender as interim CEO| (NASDAQ: BCYC) | Delayed: 3.74 +0.11 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.63 | 52 Week High | $ | |||
| Open | $3.67 | 52 Week Low | $ | |||
| Day High | $3.83 | P/E | N/A | |||
| Day Low | $3.65 | EPS | $ | |||
| Volume | 321,286 | |||||
| (NASDAQ: MCRB) | Delayed: 4.00 -0.07 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.07 | 52 Week High | $44.51 | |||
| Open | $4.13 | 52 Week Low | $8.05 | |||
| Day High | $4.15 | P/E | N/A | |||
| Day Low | $3.93 | EPS | $0.00 | |||
| Volume | 10,629 | |||||
